Angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) are recommended widely as first-line treatments for hypertension in patients with diabetic or nondiabetic ...

angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-II receptor blockers (ARBs) are thought to have specific renoprotective effects in patients with diabetic and nondiabetic nephropathy.

To test the hypothesis that an angiotensin-receptor blocker (ARB), either alone or combined with an ACE inhibitor, is more effective than an ACE inhibitor alone in high-risk patients after MI ...

Inhibition of the renin–angiotensin system using either an angiotensin-converting-enzyme (ACE) inhibitor or an angiotensin-receptor blocker (ARB) effectively decreases rates of urinary protein ...

Many people diagnosed with hypertension are prescribed angiotensin-converting enzyme inhibitors—better known as ACE-1 inhibitors (ACEIs)—and/or angiotensin receptor blockers (ARBs), which act ...